Phibro Animal Health (NASDAQ:PAHC) Hits New 1-Year High on Analyst Upgrade

Shares of Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday after Barclays raised their price target on the stock from $20.00 to $22.00. Barclays currently has an underweight rating on the stock. Phibro Animal Health traded as high as $26.42 and last traded at $26.22, with a volume of 874178 shares. The stock had previously closed at $23.69.

A number of other equities research analysts have also recently weighed in on the company. Morgan Stanley boosted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research note on Tuesday, December 17th. StockNews.com downgraded shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, February 6th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $21.00.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP purchased a new stake in shares of Phibro Animal Health in the third quarter valued at approximately $70,000. nVerses Capital LLC purchased a new stake in shares of Phibro Animal Health in the third quarter valued at approximately $70,000. Aquatic Capital Management LLC purchased a new position in shares of Phibro Animal Health in the 4th quarter valued at about $69,000. China Universal Asset Management Co. Ltd. increased its holdings in shares of Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company's stock valued at $88,000 after purchasing an additional 1,522 shares in the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in shares of Phibro Animal Health in the 4th quarter valued at about $113,000. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

The stock's fifty day moving average price is $22.07 and its 200-day moving average price is $21.84. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.69 and a current ratio of 3.20. The firm has a market cap of $1.04 billion, a PE ratio of 53.69, a P/E/G ratio of 0.53 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, equities analysts forecast that Phibro Animal Health Co. will post 1.94 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.86%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health's dividend payout ratio is currently 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.